Searcharxiv⌕ Search

arXiv subjects

James R. M. Black

Publications and source records attributed to James R. M. Black.

3 recordsLinked to original sources

Open-weight genome language model safeguards: Assessing robustness via adversarial fine-tuning

Novel deep learning architectures are increasingly being applied to biological data, including genetic sequences. These models, referred to as genomic language models (gLMs), have demonstrated impressive predictive and generative capabilities, raising concerns that such models may also enable misuse, for instance via the generation of genomes for human-infecting viruses. These concerns have catalyzed calls for risk mitigation measures. The de facto mitigation of choice is filtering of pretraining data (i.e., removing viral genomic sequences from training datasets) in order to limit gLM performance on virus-related tasks. However, it is not currently known how robust this approach is for securing open-source models that can be fine-tuned using sensitive pathogen data. Here, we evaluate a state-of-the-art gLM, Evo 2, and perform fine-tuning using sequences from 110 harmful human-infecting viruses to assess the rescue of misuse-relevant predictive capabilities. The fine-tuned model exhibited reduced perplexity on unseen viral sequences relative to 1) the pretrained model and 2) a version fine-tuned on bacteriophage sequences. The model fine-tuned on human-infecting viruses also identified immune escape variants from SARS-CoV-2 (achieving an AUROC of 0.6), despite having no exposure to SARS-CoV-2 sequences during fine-tuning. This work demonstrates that data exclusion might be circumvented by fine-tuning approaches that can, to some degree, rescue misuse-relevant capabilities of gLMs. We highlight the need for safety frameworks for gLMs and outline further work needed on evaluations and mitigation measures to enable the safe deployment of gLMs.

cs.LG↗

The science and practice of proportionality in AI risk evaluations

A global challenge in artificial intelligence (AI) regulation lies in achieving effective risk management without compromising innovation and technical progress. The European Union (EU) Artificial Intelligence Act represents the first regulatory attempt worldwide to navigate this tension in the form of a binding, risk-based framework. In August 2025, obligations for providers of general-purpose AI (GPAI) models under the EU AI Act entered into application. They require providers of the most advanced GPAI models to evaluate possible systemic risks stemming from their models. This raises the regulatory challenge of ensuring that the evaluations provide meaningful risk information without imposing excessive burden on providers. The principle of proportionality, a binding requirement under EU law, requires the regulator to calibrate its actions to their intended objectives. The application of proportionality to model evaluations for AI risk opens opportunities to develop scientific methods that operationalize such calibration within concrete evaluation practices.

cs.CY↗

Securing Dual-Use Pathogen Data of Concern

Training data is an essential input into creating competent artificial intelligence (AI) models. AI models for biology are trained on large volumes of data, including data related to biological sequences, structures, images, and functions. The type of data used to train a model is intimately tied to the capabilities it ultimately possesses--including those of biosecurity concern. For this reason, an international group of more than 100 researchers at the recent 50th anniversary Asilomar Conference endorsed data controls to prevent the use of AI for harmful applications such as bioweapons development. To help design such controls, we introduce a five-tier Biosecurity Data Level (BDL) framework for categorizing pathogen data. Each level contains specific data types, based on their expected ability to contribute to capabilities of concern when used to train AI models. For each BDL tier, we propose technical restrictions appropriate to its level of risk. Finally, we outline a novel governance framework for newly created dual-use pathogen data. In a world with widely accessible computational and coding resources, data controls may be among the most high-leverage interventions available to reduce the proliferation of concerning biological AI capabilities.

cs.AI↗